Literature DB >> 19006568

A large kindred with X-linked neutropenia with an I294T mutation of the Wiskott-Aldrich syndrome gene.

Karolien Beel1, Melanie M Cotter, Jan Blatny, Jonathan Bond, Geoff Lucas, Frances Green, Vik Vanduppen, Daisy W Leung, Sean Rooney, Owen P Smith, Michael K Rosen, Peter Vandenberghe.   

Abstract

X-linked neutropenia (XLN, OMIM #300299) is a rare form of severe congenital neutropenia. It was originally described in a three-generation family with five affected members that had an L270P mutation in the GTP-ase binding domain (GBD) of the Wiskott-Aldrich syndrome protein (WASP) [Devriendt et al (2001) Nature Genetics, Vol. 27, 313-317]. Here, we report and describe a large three-generation family with XLN, with 10 affected males and eight female carriers. A c.882T>C mutation was identified in the WAS gene, resulting in an I294T mutation. The infectious course is variable and mild in view of the profound neutropenia. In addition to the original description, low-normal IgA levels, low to low-normal platelet counts and reduced natural killer (NK)-cell counts also appear as consistent XLN features. However, inverted CD4/CD8 ratios were not found in this family, nor were cases identified with myelodysplastic syndrome or acute myeloid leukaemia. Female carriers exhibited a variable attenuated phenotype. Like L270P WASP, I294T WASP is constitutively active towards actin polymerization. In conclusion, this largest XLN kindred identified to date provides new independent genetic evidence that mutations disrupting the auto-inhibitory GBD of WASP are the cause of XLN. Reduced NK cells, low to low normal platelet counts and low to low-normal IgA levels are also features of XLN.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19006568      PMCID: PMC3125974          DOI: 10.1111/j.1365-2141.2008.07416.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  13 in total

1.  Mutation nomenclature extensions and suggestions to describe complex mutations: a discussion.

Authors:  J T den Dunnen; S E Antonarakis
Journal:  Hum Mutat       Date:  2000       Impact factor: 4.878

2.  X inactivation in females with X-linked disease.

Authors:  J M Puck; H F Willard
Journal:  N Engl J Med       Date:  1998-01-29       Impact factor: 91.245

3.  Two novel activating mutations in the Wiskott-Aldrich syndrome protein result in congenital neutropenia.

Authors:  Phil J Ancliff; Michael P Blundell; Giles O Cory; Yolanda Calle; Austen Worth; Helena Kempski; Siobhan Burns; Gareth E Jones; Jo Sinclair; Christine Kinnon; Ian M Hann; Rosemary E Gale; David C Linch; Adrian J Thrasher
Journal:  Blood       Date:  2006-06-27       Impact factor: 22.113

4.  Constitutively activating mutation in WASP causes X-linked severe congenital neutropenia.

Authors:  K Devriendt; A S Kim; G Mathijs; S G Frints; M Schwartz; J J Van Den Oord; G E Verhoef; M A Boogaerts; J P Fryns; D You; M K Rosen; P Vandenberghe
Journal:  Nat Genet       Date:  2001-03       Impact factor: 38.330

5.  Congenital neutropenia and low serum immunoglobulin A: description and investigation of a large kindred.

Authors:  E F Cryan; P F Deasy; R J Buckley; J F Greally
Journal:  Thymus       Date:  1988

6.  Incidence of CSF3R mutations in severe congenital neutropenia and relevance for leukemogenesis: Results of a long-term survey.

Authors:  Manuela Germeshausen; Matthias Ballmaier; Karl Welte
Journal:  Blood       Date:  2006-09-19       Impact factor: 22.113

7.  Nonrandom X-inactivation patterns in normal females: lyonization ratios vary with age.

Authors:  L Busque; R Mio; J Mattioli; E Brais; N Blais; Y Lalonde; M Maragh; D G Gilliland
Journal:  Blood       Date:  1996-07-01       Impact factor: 22.113

8.  Patients with high-risk myelodysplastic syndrome can have polyclonal or clonal haemopoiesis in complete haematological remission.

Authors:  M Delforge; H Demuynck; G Verhoef; P Vandenberghe; P Zachée; J Maertens; V Van Duppen; M A Boogaerts
Journal:  Br J Haematol       Date:  1998-07       Impact factor: 6.998

9.  X-linked thrombocytopenia and Wiskott-Aldrich syndrome: similar regional assignment but distinct X-inactivation pattern in carriers.

Authors:  G De Saint-Basile; N Schlegel; M Caniglia; F Le Deist; C Kaplan; T Lecompte; F Piller; A Fischer; C Griscelli
Journal:  Ann Hematol       Date:  1991-08       Impact factor: 3.673

10.  Unregulated actin polymerization by WASp causes defects of mitosis and cytokinesis in X-linked neutropenia.

Authors:  Dale A Moulding; Michael P Blundell; David G Spiller; Michael R H White; Giles O Cory; Yolanda Calle; Helena Kempski; Jo Sinclair; Phil J Ancliff; Christine Kinnon; Gareth E Jones; Adrian J Thrasher
Journal:  J Exp Med       Date:  2007-08-27       Impact factor: 14.307

View more
  31 in total

Review 1.  Immunological loss-of-function due to genetic gain-of-function in humans: autosomal dominance of the third kind.

Authors:  Bertrand Boisson; Pierre Quartier; Jean-Laurent Casanova
Journal:  Curr Opin Immunol       Date:  2015-01-31       Impact factor: 7.486

2.  Molecular basis of congenital neutropenia.

Authors:  Christoph Klein
Journal:  Haematologica       Date:  2009-10       Impact factor: 9.941

3.  A congenital activating mutant of WASp causes altered plasma membrane topography and adhesion under flow in lymphocytes.

Authors:  Siobhan O Burns; David J Killock; Dale A Moulding; Joao Metelo; Joao Nunes; Ruth R Taylor; Andrew Forge; Adrian J Thrasher; Aleksandar Ivetic
Journal:  Blood       Date:  2010-03-30       Impact factor: 22.113

Review 4.  When Actin is Not Actin' Like It Should: A New Category of Distinct Primary Immunodeficiency Disorders.

Authors:  Evelien G G Sprenkeler; Steven D S Webbers; Taco W Kuijpers
Journal:  J Innate Immun       Date:  2020-08-26       Impact factor: 7.349

Review 5.  New monogenic disorders identify more pathways to neutropenia: from the clinic to next-generation sequencing.

Authors:  Seth J Corey; Usua Oyarbide
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2017-12-08

6.  Excess F-actin mechanically impedes mitosis leading to cytokinesis failure in X-linked neutropenia by exceeding Aurora B kinase error correction capacity.

Authors:  Dale A Moulding; Emad Moeendarbary; Leo Valon; Julien Record; Guillaume T Charras; Adrian J Thrasher
Journal:  Blood       Date:  2012-09-12       Impact factor: 22.113

7.  Mouse T cell priming is enhanced by maturation-dependent stiffening of the dendritic cell cortex.

Authors:  Daniel Blumenthal; Vidhi Chandra; Lyndsay Avery; Janis K Burkhardt
Journal:  Elife       Date:  2020-07-27       Impact factor: 8.140

Review 8.  WASP: a key immunological multitasker.

Authors:  Adrian J Thrasher; Siobhan O Burns
Journal:  Nat Rev Immunol       Date:  2010-03       Impact factor: 53.106

9.  Activating WASP mutations associated with X-linked neutropenia result in enhanced actin polymerization, altered cytoskeletal responses, and genomic instability in lymphocytes.

Authors:  Lisa S Westerberg; Parool Meelu; Marisa Baptista; Michelle A Eston; David A Adamovich; Vinicius Cotta-de-Almeida; Brian Seed; Michael K Rosen; Peter Vandenberghe; Adrian J Thrasher; Christoph Klein; Frederick W Alt; Scott B Snapper
Journal:  J Exp Med       Date:  2010-05-31       Impact factor: 14.307

Review 10.  Mutations of the Wiskott-Aldrich Syndrome Protein affect protein expression and dictate the clinical phenotypes.

Authors:  Hans D Ochs
Journal:  Immunol Res       Date:  2009       Impact factor: 2.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.